Resilience and Equity in Aging, Cancer, and Health (REACH)

Launched by DANA-FARBER CANCER INSTITUTE · Dec 14, 2020

Keywords

ClinConnect Summary

The REACH trial is a research study that aims to find out how consulting with a specialized doctor for older adults, known as a geriatrician, can improve care for patients aged 70 and older who have gastrointestinal cancers, such as cancers of the stomach, colon, or pancreas. The study is currently recruiting participants who will continue their care at the Dana-Farber Brigham Cancer Center (DF/BWCC) after their initial visit and who can speak either English or Spanish.

To be eligible for the trial, participants must be at least 70 years old and have been diagnosed with one of the specific types of gastrointestinal cancer. If you or a loved one meets these criteria, you can expect to receive personalized care that combines oncology (cancer treatment) with geriatric expertise to help improve health outcomes and quality of life. The study will help researchers understand the best ways to support older patients during their cancer treatment journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are age 70+ at time of initial consult at DF/BWCC
• • Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
• • Continuing care at DF/BWCC beyond initial consult visit
• • English and Spanish-speaking
• Exclusion Criteria:
• • Patients less than age 70 at time of initial consultation appointment with DF/BWCC.
• • Patients who are not continuing care at DF/BWCC beyond first consult visit.
• • Not proficient in English or Spanish
• • Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
• • Participants with psychiatric illness/social situations that would limit compliance with study requirements.